Chapter

Smoking cessation

Onn Min Kon and Susannah A.A. Bloch

in Chronic Obstructive Pulmonary Disease (COPD)

Published on behalf of Oxford University Press

ISBN: 9780199549146
Published online May 2011 | e-ISBN: 9780199607273 | DOI: http://dx.doi.org/10.1093/med/9780199549146.003.0005

Series: Oxford Respiratory Medicine Library

Smoking cessation

More Like This

Show all results sharing this subject:

  • Respiratory Medicine and Pulmonology

GO

Show Summary Details

Preview

• Smoking cessation is currently the only intervention that causes a slowing in the natural history of an accelerated loss of forced expiratory volume in 1s (FEV1) in COPD. • The addictive properties of nicotine in tobacco are mediated primarily through the release of dopamine in the nucleus accumbens via nicotinic receptors. • Smoking advice should be carried out regularly by all health professionals and has been shown to be effective. • Both behavioural therapy and pharmacological therapies have been shown to be effective in achieving smoking cessation. • Nicotine replacement, bupropion, and varenicline are first-line agents that increase the likelihood of successful smoking cessation.

Chapter.  2551 words. 

Subjects: Respiratory Medicine and Pulmonology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.